MYMX as of 1pm est, was trading at 0.0645 +0.0352 (120.14%) on 4.7 mil plus. The company’s 30 day average is only about 170k shares per day, so you can see the huge increase. When I checked the NEWS, there has not been anything recent, nor has their been any recent filings.
So, the best place to find out what may or may not be going on is to check the message boards. Sifting and sorting through the hype is never easy, but one post stood out with info on the company. Could be yet another case of an investor doing good DD (due diligence) and when shared with the investor community, someone with a following picks it up and momentum is started… sharks smell blood (or in this case money) and the rest is history.
Post: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133041404
About MYMX
Mymetics Corporation is US registered biotechnology company with its main offices in Switzerland and the Netherlands. Focused on developing next generation preventative vaccines for infectious diseases. Mymetics core technology and expertise are in the use of virosomes, lipid-based carriers containing functional fusion viral proteins in combination with rationally designed antigens and membrane proteins.
Mymetics currently has 5 vaccines in its pipeline:
HIV/AIDS
Intranasal Influenza
RSV
Chikungunya
Malaria